Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Omadacycline for Bacterial Infections.

Edelstein PH.

N Engl J Med. 2019 May 23;380(21):2072-2073. doi: 10.1056/NEJMc1903821. No abstract available.

PMID:
31116926
2.

Revisiting the timetable of tuberculosis.

Behr MA, Edelstein PH, Ramakrishnan L.

BMJ. 2018 Aug 23;362:k2738. doi: 10.1136/bmj.k2738. No abstract available.

3.

Bacteremia caused by the photosynthetic environmental bacterium Rhodopseudomonas.

Mitchell SL, Blumberg EA, Edelstein PH.

J Infect Chemother. 2017 Oct;23(10):720-723. doi: 10.1016/j.jiac.2017.04.001. Epub 2017 Apr 21.

PMID:
28438461
4.

Legionella jamestowniensis fatal pneumonia in an immunosuppressed man.

Edelstein PH.

J Infect Chemother. 2017 Jan;23(1):59-61. doi: 10.1016/j.jiac.2016.07.015. Epub 2016 Aug 28.

PMID:
27578025
5.

Reply to "The infallible microbial identification test: does it exist?".

Alby K, Glaser LJ, Edelstein PH.

J Clin Microbiol. 2015 May;53(5):1787. doi: 10.1128/JCM.00310-15. No abstract available.

6.
7.

Nuclemeter: a reaction-diffusion based method for quantifying nucleic acids undergoing enzymatic amplification.

Liu C, Sadik MM, Mauk MG, Edelstein PH, Bushman FD, Gross R, Bau HH.

Sci Rep. 2014 Dec 5;4:7335. doi: 10.1038/srep07335.

8.

Imipenem therapy for Legionnaires' disease.

Edelstein PH.

J Infect Chemother. 2015 Jan;21(1):76. doi: 10.1016/j.jiac.2014.08.034. Epub 2014 Oct 31. No abstract available.

PMID:
25443312
10.
11.

The Bristol stool scale and its relationship to Clostridium difficile infection.

Caroff DA, Edelstein PH, Hamilton K, Pegues DA; CDC Prevention Epicenters Program.

J Clin Microbiol. 2014 Sep;52(9):3437-9. doi: 10.1128/JCM.01303-14. Epub 2014 Jul 16.

12.

Detection of methicillin-resistant coagulase-negative staphylococci by the Vitek 2 system.

Johnson KN, Andreacchio K, Edelstein PH.

J Clin Microbiol. 2014 Sep;52(9):3196-9. doi: 10.1128/JCM.01162-14. Epub 2014 Jun 20.

13.

Prevalence and detection of mixed-population enterococcal bacteremia.

Cárdenas AM, Andreacchio KA, Edelstein PH.

J Clin Microbiol. 2014 Jul;52(7):2604-8. doi: 10.1128/JCM.00802-14. Epub 2014 May 14.

14.

Abdominal abscess caused by Mycobacterium llatzerense.

Cárdenas AM, Gomila M, Lalucat J, Edelstein PH.

J Clin Microbiol. 2014 Apr;52(4):1287-9. doi: 10.1128/JCM.03525-13. Epub 2014 Jan 29.

15.

Membrane-based, sedimentation-assisted plasma separator for point-of-care applications.

Liu C, Mauk M, Gross R, Bushman FD, Edelstein PH, Collman RG, Bau HH.

Anal Chem. 2013 Nov 5;85(21):10463-70. doi: 10.1021/ac402459h. Epub 2013 Oct 25.

16.

Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Szumowski JD, Adams KN, Edelstein PH, Ramakrishnan L.

Curr Top Microbiol Immunol. 2013;374:81-108. doi: 10.1007/82_2012_300.

17.

The Guinea pig model of legionnaires' disease.

Edelstein PH.

Methods Mol Biol. 2013;954:521-40. doi: 10.1007/978-1-62703-161-5_32.

PMID:
23150418
18.

The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.

Han JH, Edelstein PH, Bilker WB, Lautenbach E.

J Infect. 2013 Jan;66(1):41-7. doi: 10.1016/j.jinf.2012.09.001. Epub 2012 Sep 6.

19.

Risk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coli.

Han JH, Kasahara K, Edelstein PH, Bilker WB, Lautenbach E.

Antimicrob Agents Chemother. 2012 Nov;56(11):5575-80. doi: 10.1128/AAC.01136-12. Epub 2012 Aug 13.

20.

Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia.

Han JH, Mascitti KB, Edelstein PH, Bilker WB, Lautenbach E.

Antimicrob Agents Chemother. 2012 Oct;56(10):5164-70. doi: 10.1128/AAC.00757-12. Epub 2012 Jul 23.

21.

Reduced vancomycin susceptibility and staphylococcal cassette chromosome mec (SCCmec) type distribution in methicillin-resistant Staphylococcus aureus bacteraemia.

Han JH, Edelstein PH, Lautenbach E.

J Antimicrob Chemother. 2012 Oct;67(10):2346-9. doi: 10.1093/jac/dks255. Epub 2012 Jul 3.

22.

Derivation and validation of clinical prediction rules for reduced vancomycin susceptibility in Staphylococcus aureus bacteraemia.

Han JH, Bilker WB, Edelstein PH, Mascitti KB, Lautenbach E.

Epidemiol Infect. 2013 Jan;141(1):165-73. doi: 10.1017/S0950268812000295. Epub 2012 Apr 10.

23.

Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.

Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS 2nd, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA; AMERECUS Investigators.

Antimicrob Agents Chemother. 2012 May;56(5):2364-70. doi: 10.1128/AAC.05824-11. Epub 2012 Feb 21.

24.

Potential for pet animals to harbour methicillin-resistant Staphylococcus aureus when residing with human MRSA patients.

Morris DO, Lautenbach E, Zaoutis T, Leckerman K, Edelstein PH, Rankin SC.

Zoonoses Public Health. 2012 Jun;59(4):286-93. doi: 10.1111/j.1863-2378.2011.01448.x. Epub 2012 Jan 10.

25.

Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.

Mascitti KB, Edelstein PH, Fishman NO, Morales KH, Baltus AJ, Lautenbach E.

Infect Control Hosp Epidemiol. 2012 Feb;33(2):160-6. doi: 10.1086/663708. Epub 2011 Dec 20.

26.

Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era.

Liu Z, Nachamkin I, Edelstein PH, Lautenbach E, Metlay JP.

Antimicrob Agents Chemother. 2012 Feb;56(2):743-50. doi: 10.1128/AAC.05122-11. Epub 2011 Nov 28.

27.

Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study.

Margolis DJ, Fanelli M, Kupperman E, Papadopoulos M, Metlay JP, Xie SX, DiRienzo J, Edelstein PH.

Arch Dermatol. 2012 Mar;148(3):326-32. doi: 10.1001/archdermatol.2011.355. Epub 2011 Nov 21.

28.

Legionella steelei sp. nov., isolated from human respiratory specimens in California, USA, and South Australia.

Edelstein PH, Edelstein MA, Shephard LJ, Ward KW, Ratcliff RM.

Int J Syst Evol Microbiol. 2012 Aug;62(Pt 8):1766-71. doi: 10.1099/ijs.0.035709-0. Epub 2011 Sep 23.

PMID:
21948093
29.

Fatal Kytococcus schroeteri infection with crusted papules and distinctive histologic plump tetrads.

Nagler AR, Wanat KA, Bachman MA, Elder D, Edelstein PH, Schuster MG, Rosenbach M.

Arch Dermatol. 2011 Sep;147(9):1119-21. doi: 10.1001/archdermatol.2011.242. No abstract available.

PMID:
21931062
30.

Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USA.

Simmon KE, Brown-Elliott BA, Ridge PG, Durtschi JD, Mann LB, Slechta ES, Steigerwalt AG, Moser BD, Whitney AM, Brown JM, Voelkerding KV, McGowan KL, Reilly AF, Kirn TJ, Butler WR, Edelstein PH, Wallace RJ Jr, Petti CA.

Emerg Infect Dis. 2011 Sep;17(9):1692-700. doi: 10.3201/eid1709.101667.

31.

Cell mediated immunity in Legionnaires' disease.

Hoffman PS, Edelstein PH.

Vaccine. 2011 Sep 2;29(38):6437-8; author reply 6439-40. doi: 10.1016/j.vaccine.2011.06.118. Epub 2011 Jul 14. No abstract available.

PMID:
21762750
32.

Antibiotics, acne, and Staphylococcus aureus colonization.

Fanelli M, Kupperman E, Lautenbach E, Edelstein PH, Margolis DJ.

Arch Dermatol. 2011 Aug;147(8):917-21. doi: 10.1001/archdermatol.2011.67. Epub 2011 Apr 11.

33.

Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.

Adams KN, Takaki K, Connolly LE, Wiedenhoft H, Winglee K, Humbert O, Edelstein PH, Cosma CL, Ramakrishnan L.

Cell. 2011 Apr 1;145(1):39-53. doi: 10.1016/j.cell.2011.02.022. Epub 2011 Mar 3. Erratum in: Cell. 2011 Apr 1;145(1):159.

34.

Relapsing Legionella pneumophila cellulitis: a case report and review of the literature.

Han JH, Nguyen JC, Harada S, Baddour LM, Edelstein PH.

J Infect Chemother. 2010 Dec;16(6):439-42. doi: 10.1007/s10156-010-0072-6. Epub 2010 Jun 5. Review.

PMID:
20526646
35.

Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era.

Metlay JP, Lautenbach E, Li Y, Shults J, Edelstein PH.

Arch Intern Med. 2010 Apr 26;170(8):725-31. doi: 10.1001/archinternmed.2010.53.

36.
37.

Prevalence of non-penicillin-susceptible group B streptococcus in Philadelphia and specificity of penicillin resistance screening methods.

Kasahara K, Baltus AJ, Lee SH, Edelstein MA, Edelstein PH.

J Clin Microbiol. 2010 Apr;48(4):1468-9. doi: 10.1128/JCM.02296-09. Epub 2010 Jan 27.

38.

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO.

Infect Control Hosp Epidemiol. 2009 Dec;30(12):1180-5. doi: 10.1086/648451.

39.

Fluoroquinolone-resistant Pseudomonas aeruginosa in chronic rhinosinusitis.

Guss J, Abuzeid WM, Doghramji L, Edelstein PH, Chiu AG.

ORL J Otorhinolaryngol Relat Spec. 2009;71(5):263-7. doi: 10.1159/000242428. Epub 2009 Sep 30. Erratum in: ORL J Otorhinolaryngol Relat Spec. 2010;72(4):232. Abuzeid, W M [added].

PMID:
19797934
40.

Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania.

McGettigan SE, Hu B, Andreacchio K, Nachamkin I, Edelstein PH.

J Clin Microbiol. 2009 Sep;47(9):2970-4. doi: 10.1128/JCM.00319-09. Epub 2009 Jul 8.

41.

Legionella pneumophila goes clonal--Paris and Lorraine strain-specific risk factors.

Edelstein PH, Metlay JP.

Clin Infect Dis. 2009 Jul 15;49(2):192-4. doi: 10.1086/599826. No abstract available.

42.

Specificity of ertapenem susceptibility screening for detection of Klebsiella pneumoniae carbapenemases.

McGettigan SE, Andreacchio K, Edelstein PH.

J Clin Microbiol. 2009 Mar;47(3):785-6. doi: 10.1128/JCM.02143-08. Epub 2009 Jan 14.

43.

Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults.

Flory JH, Joffe M, Fishman NO, Edelstein PH, Metlay JP.

Epidemiol Infect. 2009 May;137(5):717-26. doi: 10.1017/S0950268808001489. Epub 2008 Oct 17.

44.

Treatment and outcomes for patients with bacteremic pneumococcal pneumonia.

Berjohn CM, Fishman NO, Joffe MM, Edelstein PH, Metlay JP.

Medicine (Baltimore). 2008 May;87(3):160-6. doi: 10.1097/MD.0b013e318178923a.

45.

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline.

Anthony KB, Fishman NO, Linkin DR, Gasink LB, Edelstein PH, Lautenbach E.

Clin Infect Dis. 2008 Feb 15;46(4):567-70. doi: 10.1086/526775.

PMID:
18199038
46.
47.

Why is long-term therapy required to cure tuberculosis?

Connolly LE, Edelstein PH, Ramakrishnan L.

PLoS Med. 2007 Mar;4(3):e120. No abstract available.

48.

Urine antigen tests positive for Pontiac fever: implications for diagnosis and pathogenesis.

Edelstein PH.

Clin Infect Dis. 2007 Jan 15;44(2):229-31. Epub 2006 Dec 8. No abstract available.

PMID:
17173222
49.

Macrolide resistance in adults with bacteremic pneumococcal pneumonia.

Metlay JP, Fishman NO, Joffe MM, Kallan MJ, Chittams JL, Edelstein PH.

Emerg Infect Dis. 2006 Aug;12(8):1223-30.

50.

Deja vu all over again: rapid enumeration of Legionella pneumophila in water.

Edelstein PH.

Appl Environ Microbiol. 2006 Jan;72(1):980. No abstract available.

Supplemental Content

Loading ...
Support Center